Research Article | Open Access
Jagan A. Pillai, Aaron Bonner-Jackson, "Review of Information and Communication Technology Devices for Monitoring Functional and Cognitive Decline in Alzheimer's Disease Clinical Trials", Journal of Healthcare Engineering, vol. 6, Article ID 813170, 14 pages, 2015. https://doi.org/10.1260/2040-22188.8.131.52
Review of Information and Communication Technology Devices for Monitoring Functional and Cognitive Decline in Alzheimer's Disease Clinical Trials
Detecting and monitoring early cognitive impairment in Alzheimer's disease (AD) is a significant need in the field of AD therapeutics. Successful AD clinical trial designs have to overcome challenges related to the subtle nature of early cognitive changes. Continuous unobtrusive assessments using Information and Communication Technology (ICT) devices to capture markers of intra-individual change over time to assess cognitive and functional disability therefore offers significant benefits. We review the literature and provide an overview on randomized clinical trials in AD that use intelligent systems to monitor functional decline, as well as strengths, weaknesses, and future directions for the use of ICTs in a new generation of AD clinical trials.
- World Health Organization, WHO Mental Health Gap Action Programme (mhGAP) 2008. Accessed September 09, 2014. http://www.who.int/mental_health/mhgap/en/.
- R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goate, N. C. Fox et al., “Clinical and biomarker changes in dominantly inherited Alzheimer's disease,” N Engl J Med, vol. 367, no. 9, pp. 795–804, 2012.
- J. A. Pillai and J. L. Cummings, “Clinical trials in predementia stages of Alzheimer disease,” Med Clin North Am, vol. 97, no. 3, pp. 439–457, 2013.
- N. B. Silverberg, L. M. Ryan, M. C. Carrillo, R. Sperling, R. C. Petersen, H. B. Posner et al., “Assessment of cognition in early dementia,” Alzheimers Dement, vol. 7, no. 3, pp. e60–e76, 2011.
- P. H. Robert, A. Konig, S. Andrieu, F. Bremond, I. Chemin, P. C. Chung et al., “Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting,” J Nutr Health Aging, vol. 17, no. 8, pp. 653–660, 2013.
- S. S. Bassett and M. F. Folstein, “Cognitive impairment and functional disability in the absence of psychiatric diagnosis,” Psychol Med, vol. 21, pp. 77–84, 1991.
- E. J. Warren, A. Grek, and D. Conn, “A correlation between cognitive performance and daily functioning in elderly people,” J Geriatr Psychiatry Neurol, vol. 2, pp. 96–100, 1989.
- D. J. Moritz, S. Kasl, and L. F. Berman, “Cognitive functioning and the incidence of limitations in activities of daily living in an elderly community sample,” Am J Epidemiol, vol. 141, pp. 41–49, 1995.
- S. A. Black and R. D. Rush, “Cognitive and Functional Decline in Adults Aged 75 and Older,” Journal of the American Geriatrics Society, vol. 50, pp. 1978–1986, 2002.
- G. M. McKhann, D. S. Knopman, H. Chertkow et al., “The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease,” Alzheimers Dement, vol. 7, no. 3, pp. 263–269, 2011.
- M. Alwan, S. Dalal, D. Mack, SW. Kell, B. Turner, J. Leachtenauer et al., “Impact of monitoring technology in assisted living: outcome pilot,” IEEE Trans Inf Technol Biomed, vol. 10, no. 1, pp. 192–198, 2006.
- T. Suzuki and S. Murase, “Influence of outdoor activity and indoor activity on cognition decline: use of an infrared sensor to measure activity,” Telemed J E Health, vol. 16, no. 6, pp. 686–690, 2010.
- T. L. Hayes, F. Abendroth, A. Adami, M. Pavel, T. A. Zitzelberger, and J. A. Kaye, “Unobtrusive assessment of activity patterns associated with mild cognitive impairment,” Alzheimers Dement, vol. 4, no. 6, pp. 395–405, 2008.
- T. L. Hayes, N. Larimer, A. Adami, and J. A. Kaye, “Medication adherence in healthy elders: small cognitive changes make a big difference,” J Aging Health, vol. 21, no. 4, pp. 567–580, 2009.
- W. Kearns, J. Fozard, V. Nams, and J. Craighead, “Wireless telesurveillance system for detecting dementia,” Gerontechnology, vol. 10, no. 2, pp. 90–102, 2011.
- J. Kaye, N. Mattek, H. H. Dodge et al., “Unobtrusive measurement of daily computer use to detect mild cognitive impairment,” Alzheimers Dement, vol. 10, no. 1, pp. 10–17, 2014.
- C. Galambos, M. Skubic, S. Wang, and M. Rantz, “Management of Dementia and Depression Utilizing In-Home Passive Sensor Data,” Gerontechnology, vol. 11, no. 3, pp. 457–468, 2013.
- P. N. Dawadi, D. J. Cook, M. Schmitter-Edgecombe, and C. Parsey, “Automated assessment of cognitive health using smart home technologies,” Technol Health Care, vol. 21, no. 4, pp. 323–343, 2013.
- T. L. Hayes, T. Riley, N. Mattek, M. Pavel, and J. A. Kaye, “Sleep habits in mild cognitive impairment,” Alzheimer Dis Assoc Disord, vol. 28, no. 2, pp. 145–150, 2014.
- E. J. Scherder, E. J. Van Someren, and D. F. Swaab, “Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease,” Behav Brain Res, vol. 101, no. 1, pp. 105–107, 1999.
- S. Ancoli-Israel, J. L. Martin, D. F. Kripke, M. Marler, and M. R. Klauber, “. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients,” J Am Geriatr Soc, vol. 50, no. 2, pp. 282–289, 2002.
- C. Singer, R. E. Tractenberg, J. Kaye, K. Schafer, A. Gamst, M. Grundman et al., “A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease,” Sleep, vol. 26, no. 7, pp. 893–901, 2003.
- G. A. Dowling, E. M. Hubbard, J. Mastick, J. S. Luxenberg, R. L. Burr, and E. J. Van Someren, “Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease,” Int Psychogeriatr, vol. 17, no. 2, pp. 221–236, 2005.
- G. A. Dowling, J. Mastick, E. M. Hubbard, J. S. Luxenberg, and R. L. Burr, “Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease,” Int J Geriatr Psychiatry, vol. 20, no. 8, pp. 738–743, 2005.
- S. Ancoli-Israel, J. Amatniek, S. Ascher, K. Sadik, and K. Ramaswamy, “Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study,” Alzheimer Dis Assoc Disord, vol. 19, no. 4, pp. 240–245, 2005.
- E. J. Scherder, M. J. van Tol, and D. F. Swaab, “High-frequency cranial electrostimulation (CES) in patients with probable Alzheimer's disease,” Am J Phys Med Rehabil, vol. 85, no. 7, pp. 614–618, 2006.
- P. D. Sloane, C. S. Williams, C. M. Mitchell, J. S. Preisser, W. Wood, A. L. Barrick et al., “High-intensity environmental light in dementia: effect on sleep and activity,” J Am Geriatr Soc, vol. 55, no. 10, pp. 1524–1533, 2007.
- R. Mahlberg, S. Walther, U. Eichmann, F. Tracik, and D. Kunz, “Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study,” Arch Gerontol Geriat, vol. 45, no. 1, pp. 19–26, 2007.
- G. A. Dowling, R. L. Burr, E. J. Van Someren, E. M. Hubbard, J. S. Luxenberg, J. Mastick et al., “Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease,” J Am Geriatr Soc, vol. 56, no. 2, pp. 239–246, 2008.
- P. R. Gehrman, D. J. Connor, J. L. Martin, T. Shochat, J. Corey-Bloom, and S. Ancoli-Israel, “Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease,” Am J Geriatr Psychiatry, vol. 17, no. 2, pp. 166–169, 2009.
- L. H. Eggermont, C. G. Blankevoort, and E. J. Scherder, “Walking and night-time restlessness in mild-tomoderate dementia: a randomized controlled trial,” Age Ageing, vol. 39, no. 6, pp. 746–749, 2010.
- S. M. McCurry, K. C. Pike, M. V. Vitiello, R. G. Logsdon, E. B. Larson, and L. Teri, “Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial,” J Am Geriatr Soc, vol. 59, no. 8, pp. 1393–13402, 2011.
- E. F. Camargos, L. L. Louzada, J. L. Quintas, J. O. Naves, F. M. Louzada, and O. T. Nobrega, “Trazodone Improves Sleep Parameters in Alzheimer Disease Patients: A Randomized, Double-Blind, and Placebo-Controlled Study,” Am J Geriatr Psychiatry, vol. 22, no. 12, pp. 1565–1574, 2014.
- A. M. Hooghiemstra, L. H. Eggermont, P. Scheltens, W. M. van der Flier, J. Bakker, M. H. de Greef et al., “Study protocol: EXERcise and cognition in sedentary adults with early-ONset dementia (EXERCISEON),” BMC Neurol, vol. 12, no. 75, Article ID 20121275, 2012.
- T. Liu-Ambrose, J. J. Eng, L. A. Boyd, C. Jacova, J. C. Davis, S. Bryan et al., “Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment,” BMC Neurol, vol. 10, no. 14, 2010.
- C. J. Farran, B. A. Staffileno, D. W. Gilley, J. J. McCann, L. Yan, C. M. Castro et al., “A lifestyle physical activity intervention for caregivers of persons with Alzheimer's disease,” Am J Alzheimers Dis Other Demen, vol. 23, no. 2, pp. 132–142, 2008.
- N. Shoval, G. K. Auslander, T. Freytag, R. Landau, F. Oswald, U. Seidl et al., “The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases,” BMC Geriatr, vol. 8, no. 7, 2008.
- A. S. Buchman, P. A. Boyle, L. Yu, R. C. Shah, R. S. Wilson, and D. A. Bennett, “Total daily physical activity and the risk of AD and cognitive decline in older adults,” Neurology, vol. 78, no. 17, pp. 1323–1329, 2012.
- S. Ancoli-Israel, R. Cole, C. Alessi, M. Chambers, W. Moorcroft, and C. P. Pollak, “The role of actigraphy in the study of sleep and circadian rhythms,” Sleep, vol. 26, no. 3, pp. 342–392, 2003.
- K. Wild, L. Boise, J. Lundell, and A. Foucek, “Unobtrusive In-Home Monitoring of Cognitive and Physical Health: Reactions and Perceptions of Older Adults,” J Appl Gerontol, vol. 27, no. 2, pp. 181–200, 2008.
- R. McCarney, J. Warner, S. Iliffe, R. van Haselen, M. Griffin, and P. Fisher, “The Hawthorne Effect: a randomised, controlled trial,” BMC Med Res Methodol, vol. 7, no. 30, 2007.
- M. Hodges, N. Kirsch, M. Newman, and M. Pollack, “Automatic assessment of cognitive impairment through electronic observation of object usage,” in Proceedings of the International Conference on Pervasive Computing, pp. 192–209, Springer-Verlag, Berlin, Heidelberg, 2010.
- D. A. Snowdon, S. J. Kemper, J. A. Mortimer, L. H. Greiner, D. R. Wekstein, and W. R. Markesbery, “Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study,” JAMA, vol. 275, no. 7, pp. 528–532, 1996.
- S. Kemper, L. H. Greiner, J. G. Marquis, K. Prenovost, and T. L. Mitzner, “Language decline across the life span: findings from the Nun Study,” Psychol Agin, vol. 16, no. 2, pp. 227–239, 2001.
- W. Kintsch and J. Keenan, “Reading rate and retention as a function of the number of propositions in the base structure of sentences,” Cognit. Psychol, vol. 5, no. 3, pp. 257–274, 1973.
- S. T. Farias, V. Chand, L. Bonnici, K. Baynes, D. Harvey, D. Mungas et al., “Idea density measured in late life predicts subsequent cognitive trajectories: implications for the measurement of cognitive reserve,” J Gerontol B Psychol Sci Soc Sci, vol. 67, no. 6, pp. 677–686, 2012.
- S. Kemper, J. Marquis, and M. Thompson, “Longitudinal change in language production: effects of aging and dementia on grammatical complexity and propositional content,” Psychol Aging, vol. 16, no. 4, pp. 600–614, 2001.
- J. S. Ehrlich, L. K. Obler, and L. Clark, “Ideational and semantic contributions to narrative production in adults with dementia of the Alzheimer's type,” J Commun Disord, vol. 30, no. 2, pp. 79–98, 1997.
- P. Feyereisen, J. Berrewaerts, and M. Hupet, “Pragmatic skills in the early stages of Alzheimer's disease: an analysis by means of a referential communication task,” Int J Lang Commun Disord, vol. 42, no. 1, pp. 1–17, 2007.
- V. Taler and N. A. Phillips, “Language performance in Alzheimer's disease and mild cognitive impairment: a comparative review,” J Clin Exp Neuropsychol, vol. 30, no. 5, pp. 501–556, 2008.
- K. E. Forbes-McKay and A. Venneri, “Detecting subtle spontaneous language decline in early Alzheimer's disease with a picture description task,” Neurol Sci, vol. 26, no. 4, pp. 243–254, 2005.
- A. Oulhaj, G. K. Wilcock, A. D. Smith, and C. A. de Jager, “Predicting the time of conversion to MCI in the elderly: role of verbal expression and learning,” Neurology, vol. 73, no. 18, pp. 1436–1442, 2009.
- S. Ahmed, A. M. Haigh, C. A. de Jager, and P. Garrard, “Connected speech as a marker of disease progression in autopsy-proven Alzheimer's disease,” Brain, vol. 136, Pt 12, pp. 3727–3737, 2013.
- V. Chand, K. Baynes, L. Bonnici, and S. T. Farias, Analysis of Idea Density (AID): A Manual, Department of Neurology, Center for Mind and Brain, Department of Linguistics, University of California, 2010.
- H. Christensen, A. J. Mackinnon, A. Korten, and A. F. Jorm, “The, “common cause hypothesis” of cognitive aging: evidence for not only a common factor but also specific associations of age with vision and grip strength in a cross-sectional analysis,” Psychol Aging, vol. 16, no. 4, pp. 588–599, 2001.
- S. W. MacDonald, C. A. DeCarlo, and R. A. Dixon, “Linking biological and cognitive aging: toward improving characterizations of developmental time,” J Gerontol B Psychol Sci Soc Sci, vol. 66, Suppl 1, pp. i59–170, 2011.
- A. Alfaro-Acha, S. Al Snih, M. A. Raji, Y. F. Kuo, K. S. Markides, and K. J. Ottenbacher, “Handgrip strength and cognitive decline in older Mexican Americans,” J Gerontol A Biol Sci Med Sci, vol. 61, no. 8, pp. 859–865, 2006.
- P. A. Boyle, A. S. Buchman, R. S. Wilson, S. E. Leurgans, and D. A. Bennett, “Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons,” Arch Neurol, vol. 66, no. 11, pp. 1339–1344, 2009.
- J. Verghese, M. Robbins, R. Holtzer, M. Zimmerman, C. Wang, X. Xue et al., “Gait dysfunction in mild cognitive impairment syndromes,” J Am Geriatr Soc, vol. 56, no. 7, pp. 1244–1251, 2008.
- T. Buracchio, H. H. Dodge, D. Howieson, D. Wasserman, and J. Kaye, “The trajectory of gait speed preceding mild cognitive impairment,” Arch Neurol, vol. 67, no. 8, pp. 980–986, 2010.
- O. Beauchet, G. Allali, C. Launay, F. R. Herrmann, and C. Annweiler, “Gait variability at fast-pace walking speed: a biomarker of mild cognitive impairment?” J Nutr Health Aging, vol. 17, no. 3, pp. 235–239, 2013.
- H. H. Dodge, N. C. Mattek, D. Austin, T. L. Hayes, and J. A. Kaye, “In-home walking speeds and variability trajectories associated with mild cognitive impairment,” Neurology, vol. 78, no. 24, pp. 1946–1952, 2012.
- A. K. Welmer, D. Rizzuto, C. Qiu, B. Caracciolo, and E. J. Laukka, “Walking Speed, Processing Speed, and Dementia: A Population-Based Longitudinal Study,” J Gerontol A Biol Sci Med Sci, vol. 69, no. 12, pp. 1503–1510, 2014.
- J. M. Duchek, D. B. Carr, L. Hunt, C. M. Roe, C. Xiong, K. Shah et al., “Longitudinal driving performance in early-stage dementia of the Alzheimer type,” J Am Geriatr Soc, vol. 51, no. 10, pp. 1342–1247, 2003.
- B. R. Ott, W. C. Heindel, G. D. Papandonatos, E. K. Festa, J. D. Davis, L. A. Daiello et al., “A longitudinal study of drivers with Alzheimer disease,” Neurology, vol. 70, no. 14, pp. 1171–1178, 2008.
- T. J. Anderson and M. R. MacAskill, “Eye movements in patients with neurodegenerative disorders,” Nat Rev Neurol, vol. 9, no. 2, pp. 74–85, 2013.
- J. Hellmuth, J. Mirsky, H. W. Heuer, A. Matlin, A. Jafari, S. Garbutt et al., “Multicenter validation of a bedside antisaccade task as a measure of executive function,” Neurology, vol. 78, no. 23, pp. 1824–1831, 2012.
- D. P. Munoz and S. Everling, “Look away: the anti-saccade task and the voluntary control of eye movement,” Nat Rev Neurosci, vol. 5, no. 3, pp. 218–228, 2004.
- S. Ga rbutt, A. Matlin, J. Hellmuth, A. K. Schenk, J. K. Johnson, H. Rosen et al., “Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease,” Brain, vol. 131, Pt 5, pp. 1268–1281, 2008.
- H. W. Heuer, J. B. Mirsky, E. L. Kong, B. C. Dickerson, B. L. Miller, J. H. Kramer et al., “Antisaccade task reflects cortical involvement in mild cognitive impairment,” Neurology, vol. 81, no. 14, pp. 1235–1243, 2013.
- T. Blekher, S. A. Johnson, J. Marshall, K. White, S. Hui, M. Weaver et al., “Saccades in presymptomatic and early stages of Huntington disease,” Neurology, vol. 67, no. 3, pp. 394–399, 2006.
Copyright © 2015 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.